Sjögren's syndrome-like disease in mice with T cells lacking class 1A phosphoinositide-3-kinase
Open Access
- 7 November 2006
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 103 (45) , 16882-16887
- https://doi.org/10.1073/pnas.0607984103
Abstract
Sjögren's syndrome (SS) is an autoimmune disease that is characterized by infiltration of exocrine tissues, resulting in xerostomia (dry mouth) and keratoconjunctivitis sicca (dry eyes). Here, we show that mice with T cell-specific loss of class IA phosphoinositide 3-kinase function develop organ-specific autoimmunity that resembles the human disease SS. Most mutant mice aged 3–8 months develop corneal opacity and eye lesions due to irritation and constant scratching. These mice display cardinal signs of primary SS such as marked lymphocytic infiltration of the lacrimal glands, antinuclear antibodies in the serum, and elevated titer of anti-SS-A antibody, in the absence of kidney pathology. Immunofluorescence studies show the presence of numerous CD4+ T cells with a smaller number of CD8+ T cells and B cells in the lacrimal glands. CD4+ T cells from these mice exhibit aberrant differentiation in vitro. These results indicate that aberrant T cells with impaired class IA phosphoinositide 3-kinase signaling can lead to organ-specific autoimmunity. In addition, the mouse model described here represents a tool to study the pathogenesis and treatment of SS.Keywords
This publication has 42 references indexed in Scilit:
- The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolismNature Reviews Genetics, 2006
- Loss of class IA PI3K signaling in muscle leads to impaired muscle growth, insulin response, and hyperlipidemiaCell Metabolism, 2006
- Immunopathogenesis of primary Sj??gren??s syndrome: implications for disease management and therapyCurrent Opinion in Rheumatology, 2005
- The p85 regulatory subunit of phosphoinositide 3-kinase down-regulates IRS-1 signaling via the formation of a sequestration complexThe Journal of cell biology, 2005
- Role of Phosphoinositide 3-Kinase Regulatory Isoforms in Development and Actin RearrangementMolecular and Cellular Biology, 2005
- Increased levels of interleukin-10 in saliva of Sjögren’s syndrome patients. Correlation with disease activityClinical and Experimental Medicine, 2004
- Effective treatment of a mouse model of Sjögren's syndrome with eyedrop administration of anti-CD4 monoclonal antibodyArthritis & Rheumatism, 2004
- Impaired B and T Cell Antigen Receptor Signaling in p110δ PI 3-Kinase Mutant MiceScience, 2002
- Xid -Like Immunodeficiency in Mice with Disruption of the p85α Subunit of Phosphoinositide 3-KinaseScience, 1999
- Sialadenitis in IQI/Jic Mice: A New Animal Model of Sjoegren's Syndrome.The Journal of Veterinary Medical Science, 1997